ClinicalTrials.gg
CompletedNCT02614326Updated May 26, 2021

MemFlex to Prevent Depressive Relapse

A Phase 2 interventional study of Autobiographical Memory Flexibility (MemFlex) training and Psychoeducation in Major Depressive Disorder, sponsored by Medical Research Council Cognition and Brain Sciences Unit. Completed at 2 sites in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-05-26.

Sponsored by Medical Research Council Cognition and Brain Sciences Unit · Phase 2, Interventional, and Prevention

Phase
Phase 2
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

A wealth of research has demonstrated that they way in which the investigators recall our personal, autobiographical memories is influential in the course of depression. Biases in the recall of autobiographical memory occur in the midst of a depressive episode, and are shown to prolong symptoms, however these biases also remain when depression remits, and may predispose the individual towards relapse. A novel cognitive intervention, MemFlex, aims to train individuals to be flexible in their retrieval of autobiographical memories, and thereby reduce depressive relapse. Changes in memory bias may also have an effect on intermediate processes that increase risk of depression, such as rumination, impaired problem solving, and cognitive avoidance. This feasibility trial compares the effects of MemFlex and Psychoeducation in their ability to reduce memory bias and intermediate cognitive risk factors, and thereby depressive relapse, in individuals remitted from Major Depressive Disorder. Clinical outcome and process measures will be assessed immediately following completion of the intervention, at 6 months post-intervention, and at 12 months post-intervention. If encouraging, the results of this pilot trial may provide a foundation for a later phase trial.

02

Conditions studied

  • Major Depressive Disorder

Keywords

  • Depression
  • Cognitive risk factors
  • Autobiographical memory
  • Cognitive bias
  • Relapse prevention
03

In context

Depressive Disorder, Major

3,041 studies on the registry are indexed under Depressive Disorder, Major; 588 are open to participants now.

This study's planned enrollment of 70 is below the median of 79 across 2,530 interventional studies indexed under Depressive Disorder, Major.

Browse Depressive Disorder, Major studies →

Lead sponsor

Medical Research Council Cognition and Brain Sciences Unit is the lead sponsor of 8 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Meets criteria for Major Depressive Disorder but is currently in remission, indexed on the Structured Clinical Interview for the DSM (SCID; First et al., 1996)
  • 18 years of age or older

Exclusion criteria

Exclusion Criteria:

  • Meets criteria for a current Major Depressive Episode, indexed on the SCID
  • Meets criteria for another mood disorder (e.g., Bipolar disorder), indexed on the SCID
  • Current alcohol or substance dependence, or currently experiencing psychotic symptoms, indexed on the SCID
  • Experience of intellectual disability, traumatic brain injury, or other neurological condition which may impact memory recall, assessed via self-report
05

Study design

Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Memory Flexibility (MemFlex) Training

    MemFlex training draws on cognitive bias modification and memory specificity training techniques (Raes et al., 2009; Dalgleish et al., 2014). MemFlex is primarily self-guided and aims to reduce autobiographical memory biases associated with depression. The training is presented over one face-to-face session and eight self-guided sessions. In the initial session, the researcher introduces cued-recall tasks used throughout the workbook, and guides the participant in completion of the tasks. When understanding of the basic principles is satisfactory, the researcher assists the participant to set a schedule for completion of the workbook over the following four weeks. The participant will receive a phone call at the beginning of week three to check progress, and clarify any difficulties.

    Behavioral: Autobiographical Memory Flexibility (MemFlex) training

  • Placebo comparator
    Psychoeducation

    The psychoeducation condition will also complete an initial face-to-face session. This session will cover the symptoms and causes of depression, and the workbook will be introduced. The workbook will consist of eight self-guided sessions that the individual will be required to complete over four weeks. The workbook content will cover the presentation of depression and basic information on factors associated with depression, such as worry, procrastination, and sleep difficulties. Each session consists of psychological theories of the topic, followed by a series of questions about the material to ensure participant engagement. The participant will receive a phone call from a team member at the beginning of week three to check progress, and clarify any difficulties.

    Behavioral: Psychoeducation

Interventions

  • BehavioralAutobiographical Memory Flexibility (MemFlex) training

    As in experimental arm description

    Also known as: MemFlex

  • BehavioralPsychoeducation

    As in experimental arm description

06

What researchers measure

Primary outcomes

  1. Time to depressive relapse

    Length of time from post-intervention assessment to occurrence of any major depressive episode within the 12 month follow-up period

    Time frame: 12 months post-intervention

  2. Number of depression free days at 12 month follow-up

    Number of depression free days as indexed by the Longitudinal Interval Follow-up Evaluation (Keller et al., 1987)

    Time frame: 12 months post-intervention

Secondary outcomes

  1. Depressive status at 12 month follow-up

    Presence of a Major Depressive Episode as indexed by the Longitudinal Interval Follow-up Evaluation (Keller et al., 1987)

    Time frame: 12 months post-intervention

  2. Depression symptoms at 12 month follow-up

    Score on the Beck Depression Inventory

    Time frame: 12 months post-intervention

  3. Autobiographical memory retrieval

    Scores for specific and alternating blocks of the alternating instructions autobiographical memory task (Dritschel et al., 2013)

    Time frame: Measured within one week of completing the intervention

Other outcomes

  1. Rumination

    Total and sub-scale scores on the Rumination Response Scale (Treynor, Gonzalez, Nolen-Hoeksema, 2003)

    Time frame: Measured within one week of completing the intervention, six months post-intervention and 12 months post-intervention

  2. Problem solving

    The total number of means and total effectiveness scores on the abbreviated version of the Means-Ends Problem Solving task (Marx, Williams, \& Claridge, 1992)

    Time frame: Measured within one week of completing the intervention, and six months post-intervention

  3. Cognitive avoidance

    Total score on the Cognitive Avoidance Questionnaire (Sexton \& Dugas, 2008)

    Time frame: Measured within one week of completing the intervention, six months post-intervention and 12 months post-intervention

  4. Anxiety symptoms

    Total score on the Beck Anxiety Inventory (Beck \& Steer, 1993)

    Time frame: Measured within one week of completing the intervention, six months post-intervention and 12 months post-intervention

  5. Hopelessness

    Total score on the Beck Hopelessness Scale (Beck, Weissman, Lester, \& Trexler, 1974)

    Time frame: Measured within one week of completing the intervention, six months post-intervention and 12 months post-intervention

07

Study locations

2 sites
  • MRC Cognition and Brain Sciences Unit
    Cambridge, CB2 7EF, United Kingdom
  • Cambridge and Peterborough NHS Foundation Trust
    Cambridge, United Kingdom
08

References and documents

Publications

  • Beck, A., Steer, R., & Brown, G. (1996). Manual for the Beck Depression Inventory II. San Antonio, TX: Psychological Corporation.
  • Beck, A. T., & Steer, R. A. (1993). Beck Anxiety Inventory Manual. San Antonio, TX: Psychological Corporation.
  • Dritschel B, Beltsos S, McClintock SM. An "alternating instructions" version of the Autobiographical Memory Test for assessing autobiographical memory specificity in non-clinical populations. Memory. 2014;22(8):881-9. doi: 10.1080/09658211.2013.839710. Epub 2013 Nov 12. Erratum In: Memory. 2014;22(5):i. Beltosis, Stamatis[corrected to Beltsos, Stamatis]. PubMed 24215524 ↗
  • First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. New York: Biometrics Research, New York State Psychiatric Institute.
  • Treynor, W., Gonzalez, R., & Nolen-Hoeksema, S. (2003). Rumination reconsidered: A psychometric analysis. Cognitive Therapy and Research, 27, 247-259. doi: 10.1023/A:1023910315561
  • Marx EM, Williams JM, Claridge GC. Depression and social problem solving. J Abnorm Psychol. 1992 Feb;101(1):78-86. doi: 10.1037//0021-843x.101.1.78. PubMed 1537977 ↗
  • Sexton KA, Dugas MJ. The Cognitive Avoidance Questionnaire: validation of the English translation. J Anxiety Disord. 2008;22(3):355-70. doi: 10.1016/j.janxdis.2007.04.005. Epub 2007 Apr 25. PubMed 17544253 ↗
  • Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol. 1974 Dec;42(6):861-5. doi: 10.1037/h0037562. No abstract available. PubMed 4436473 ↗
  • Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC. The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987 Jun;44(6):540-8. doi: 10.1001/archpsyc.1987.01800180050009. PubMed 3579500 ↗
  • Hitchcock C, Gormley S, O'Leary C, Rodrigues E, Wright I, Griffiths K, Gillard J, Watson P, Hammond E, Werner-Seidler A, Dalgleish T. Study protocol for a randomised, controlled platform trial estimating the effect of autobiographical Memory Flexibility training (MemFlex) on relapse of recurrent major depressive disorder. BMJ Open. 2018 Jan 29;8(1):e018194. doi: 10.1136/bmjopen-2017-018194. PubMed 29382674 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2016, a primary completion of Aug 2020 and a completion of Dec 2020. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 19, 2015
First posted
Nov 25, 2015
Start
Jan 2016
Primary completionActual
Aug 2020
CompletionActual
Dec 2020
Last update
May 26, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 26, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02614326
Lead sponsor
Medical Research Council Cognition and Brain Sciences Unit
Responsible party
Sponsor
First posted
Nov 25, 2015
Start date
Jan 2016
Primary completion
Aug 2020
Completion
Dec 2020
Last update
May 26, 2021

Study contacts

Tim Dalgleish
principal investigator · Medical Research Council Cognition and Brain Sciences Unit

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion